Market Place
Sourcing Support
Imcyse Reports +ve Immune Response from Phase 2 IMPACT Type 1 Diabetes Study
13 Jan 2022 //
GLOBENEWSWIRE
Peptide-lipid nanoconstructs act site-specifically towards glioblastoma growth
27 Aug 2020 //
PHARMAEXCIPIENTS
Caladrius Biosciences Reports Top-Line Data for Ph 2a: CLBS03 for T1D
13 Feb 2019 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.